Health care practitioners are split when it comes to opinions on which provider should take the lead in prescribing pre-exposure prophylaxis (PrEP), administered to people at high risk for human immunodeficiency virus (HIV), according to a study by researchers from the University at Buffalo.
“Understanding barriers and facilitators to PrEP adoption and implementation from both current and future health care providers is key to accelerate roll-out of this preventive medication to target populations who meet clinical eligibility criteria,” said Dr. Sarahmona Przybyla, lead author and assistant professor of community health and health behavior in the University of Buffalo School of Public Health and Health Professions.
PrEP is available only to people who are HIV negative, but a debate exists within the health care and public health community about who should prescribe PrEP: HIV specialists or primary care physicians.
Dr. Przybyla and her team surveyed a small sample of clinicians in Western New York licensed to prescribe medication in New York State who had prescribed PrEP for at least three months. Participants were almost equally split on ideal provider type: 15 chose primary care physicians; 13 said any health care provider.
Said Dr. Przybyla, “This research provides support for a growing foundation of research that warrants continued efforts to incorporate PrEP into a comprehensive HIV prevention plan at local, state, and national levels.”
The paper was published online ahead of print in the Journal of the Association of Nurses in AIDS Care. Co-authors include Drs. Susan LaValley, research assistant professor of family medicine in the Jacobs School of Medicine and Biomedical Sciences at UB, and Noelle St. Vil, assistant professor in the School of Social Work.Tags: Friday Letter Submission, Publish on October 18